Trials / Terminated
TerminatedNCT04881448
A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease
Evaluation of Homogeneity Between eGFR Slopes Derived From Retrospective Clinical Practice Data and eGFR Slopes Derived From Prospectively Collected, Protocol-driven Data
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 223 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to investigate the usefulness of estimated glomerular filtration rate (eGFR) slopes derived from retrospective routine clinical practice data, compare those retrospective slopes with those generated in a prospective fashion and successively identify rapidly progressing chronic kidney disease (CKD) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | collection of serum/capillary creatinine values | collection of serum/capillary creatinine values |
Timeline
- Start date
- 2021-09-16
- Primary completion
- 2022-07-15
- Completion
- 2022-07-15
- First posted
- 2021-05-11
- Last updated
- 2023-08-04
- Results posted
- 2023-08-04
Locations
25 sites across 4 countries: United States, Germany, Hungary, Spain
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04881448. Inclusion in this directory is not an endorsement.